Bixiye
P71-22 Reimbursement Policy Changes for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2022
Natiijooyinka Raadinta
Soo bandhiga 1641 - 1650 ee natiijooyinka 3688
Bixiye
P66-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2022
Bixiye
QP80-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related PA Requirement Notification, Effective December 1, 2022
Taariikhda uu dhaqangalayo barnaamijka: Okt 12, 2022
Bixiye
QP81-22 MHCP Pharmacy Benefit Exclusion for Zynteglo®
Taariikhda uu dhaqangalayo barnaamijka: Okt 12, 2022
Bixiye
QP79-22 New Commercial Pharmacy Benefit Exclusion for Zynteglo®
Taariikhda uu dhaqangalayo barnaamijka: Okt 12, 2022
Bixiye
Pyrukynd® (mitapivat) - Commercial - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025
Bixiye
Ergotamine - Medicaid
Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Ergotamine - Commercial
Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
P60-22 New Reimbursement Policy: Wrong Surgical and Other Invasive Procedures
Taariikhda uu dhaqangalayo barnaamijka: Okt 03, 2022
Bixiye
P62-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective December 5, 2022
Taariikhda uu dhaqangalayo barnaamijka: Okt 03, 2022